Bolt Biotherapeutics Inc. (BOLT)
NASDAQ: BOLT
· Real-Time Price · USD
5.33
0.07 (1.23%)
At close: Sep 11, 2025, 2:53 PM
Bolt Biotherapeutics Revenue
Bolt Biotherapeutics reported an annual revenue of $7.69M, reflecting a -2.36% growth. For the quarter ending June 30, 2025, Bolt Biotherapeutics generated $1.8M in revenue.
Revenue (ttm)
7.69M
Revenue Growth
-2.36%
Price / Sales Ratio
53.13
Revenue / Employee
147.88K
Employees
52
Market Cap
10.21M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 7.69M | -2.36% |
| Dec 31, 2023 | 7.88M | +37.48% |
| Dec 31, 2022 | 5.73M | +354.68% |
| Dec 31, 2021 | 1.26M | +445.45% |
| Dec 31, 2020 | 231K | +7.44% |
| Dec 31, 2019 | 215K | +Infinity% |
| Dec 31, 2018 | 0 | n/a |